Aussie Peelback Inc. – Trademark Portfolio

Entity Type: 03

Aussie Peelback Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MED PLATE and AUSSIE PEELBACK. The owner is based in Petawawa, Ontario.

44 Dustin Drive

Petawawa, Ontario K8H0G2 , CA

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Aussie Peelback Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Aussie Peelback Inc. have?

Aussie Peelback Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Aussie Peelback Inc. file in?

Aussie Peelback Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.

What are Aussie Peelback Inc.'s most well-known trademarks?

Aussie Peelback Inc.'s registered trademark portfolio includes well-known marks such as MED PLATE and AUSSIE PEELBACK. These are among 2 currently registered trademarks in the portfolio.

What is Aussie Peelback Inc.'s trademark registration success rate?

Aussie Peelback Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.